A detailed history of Ieq Capital, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Ieq Capital, LLC holds 32,333 shares of PTCT stock, worth $2.43 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
32,333
Previous 60,106 46.21%
Holding current value
$2.43 Million
Previous $2.94 Million 32.4%
% of portfolio
0.01%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$43.3 - $62.88 $1.2 Million - $1.75 Million
-27,773 Reduced 46.21%
32,333 $1.98 Million
Q2 2025

Aug 14, 2025

BUY
$36.19 - $52.13 $586,676 - $845,079
16,211 Added 36.93%
60,106 $2.94 Million
Q1 2025

May 14, 2025

BUY
$41.81 - $57.17 $1.62 Million - $2.22 Million
38,804 Added 762.21%
43,895 $2.24 Million
Q4 2024

Jan 31, 2025

BUY
$34.99 - $52.07 $178,134 - $265,088
5,091 New
5,091 $229,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $5.39B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Ieq Capital, LLC Portfolio

Follow Ieq Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.